• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-025
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Embolism (1829); Ischemia (1942); Numbness (2415)
Event Date 02/11/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2019, a 25mm amplatzer pfo was selected for implant.The patient was recently diagnosed of stroke on (b)(6) 2018.The device was implanted with a 8f troqvue delivery system through the right femoral vein.The physician noticed an unexpected positional adjustment/shift in positioning of the device upon removal of the delivery system.The patient was discharged on (b)(6) 2019 and did well on the one month follow up.On (b)(6) 2020, the patient experiences an ischemic stroke.The patient had left cheek numbness and slurred speech.Symptoms were sudden onset and present constantly for 15 minutes until they resolved on their own.Medication was administered.
 
Manufacturer Narrative
Additional information for g4, g7, h2, h6, and h10.The device remained implanted.Upon review of the device history records, there were no observed artifacts related to the design, or assembly, or device acceptance inspections that indicate the design or the manufacture of the present occluder is the root cause of the observed transient ischemic attack.The attack occurred four months after the implant procedure in a patient with a history of stroke 11 months prior to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10041530
MDR Text Key190658970
Report Number2135147-2020-00201
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (y/n)N
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PFO-025
Device Catalogue Number9-PFO-025
Device Lot Number7142532
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age43 YR
-
-